Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Adecto Pharmaceuticals Logo
Adecto Pharmaceuticals CB Rank
277681
Heat Score
60
Adecto Pharmaceuticals focuses on cancer treatment and performs research work to develop a therapy based on an antibody for breast cancer.
Founded
obfuscation
Private Boston, Massachusetts, United States1-10 www.adectopharma.com/
Biotechnology
Health Care
Oncology
Pharmaceutical
Therapeutics
Overview

Adecto Pharmaceuticals
Heat Score
60

Growth Score
pts
in past quarter
Heat Score 60
2 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Adecto Pharmaceuticals

CB Rank
277681
Adecto Pharmaceuticals focuses on cancer treatment and performs research work to develop a therapy based on an antibody for breast cancer.
Founded
obfuscation
Private Boston, Massachusetts, United States1-10 www.adectopharma.com/
Biotechnology
Health Care
Oncology
Pharmaceutical
Therapeutics

Key People

Details

Legal Name Adecto Pharmaceuticals, Inc.
Operating Status Active
Company Type For Profit
Founders  Gail E. Sonenshein, Nora D. Mineva
Diversity Spotlight 
Women Founded
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

ADP2 Antibody
A mouse monoclonal antibody that targets two extracellular domains of ADAM8 to inhibit tumor growth and metastasis in ADAM8-positive cancers.
AD100 Therapeutic Antibody
A humanized dual antagonist antibody derived from ADP2 designed to inhibit ADAM8 activity in aggressive cancers, currently in preclinical development.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Contacts 2

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

125
228.95%
 in past month

IT Spend

$18.6KThis year, Adecto Pharmaceuticals is projected to spend $18.6K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Furniture Today Bedding Conference Logo
Furniture Today Bedding Conference
76

Active Website Tech Count

28Adecto Pharmaceuticals is actively using 28 technologies for its website, according to BuiltWith. These include SSL by Default, Viewport Meta, and  LetsEncrypt.
Sub-Organizations
Frequently Asked Questions

Where is Adecto Pharmaceuticals's headquarters? Adecto Pharmaceuticals is located in Boston, Massachusetts, United States.Who are Adecto Pharmaceuticals's competitors? Alternatives and possible competitors to Adecto Pharmaceuticals may include Harbour Biomed, Vor Biopharma, and  Lyell Immunopharma.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(f7db04b 1)
|